AngioGenex, Inc. (fka AGGX)

[e-ore]

Chief research scientist for AGGX is Robert Benezra, PhD, a noted researcher

https://www.mskcc.org/research-areas/labs/robert-benezra

http://archive.sciencewatch.com/inter/aut/2011/11-mar/11marBene/

http://www.bcrfcure.org/researchers/robert-benezra

From Bloomberg:

"Dr. Robert Benezra, Ph.D. serves as Chairman of Scientific Advisory Board and Chief Scientific Officer at AngioGenex, Inc. Dr. Benezra has been a Member of Scientific Advisory Board of Provista Diagnostics, Inc. since June 28, 2012. Dr. Benezra serves as a Member of the Cell Biology Program at Memorial Sloan-Kettering Cancer Center. Dr. Benezra is Professor of Biology at Cornell Graduate School of Medical Sciences in New York City. Before joining Sloan-Kettering, Dr. Benezra worked at Fred Hutchinson Cancer Center in Seattle where he identified the Id proteins as dominant negative regulators of the helix-loop-helix protein family and has gone on to identify these proteins as key regulators of tumor growth, angiogenesis and metastasis. Dr. Benezra has been a Director of AngioGenex, Inc. since June 18, 2014. He has received fellowships and grant awards from the National Institutes of Health, the National Science Foundation and the American Cancer Society. Dr. Benezra received his doctorate in Biological Sciences at Columbia University in 1996."